Evasión Tumoral y Nuevas Dianas
Dana–Farber Cancer Institute
Boston, Estados UnidosPublications en collaboration avec des chercheurs de Dana–Farber Cancer Institute (3)
2023
-
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening
Nature Communications, Vol. 14, Núm. 1
2022
-
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Nature Immunology, Vol. 23, Núm. 10, pp. 1495-1506
2019
-
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Nature, Vol. 565, Núm. 7737, pp. 43-48